5th Feb 2007 07:01
International Medical Devices PLC05 February 2007 5 February 2007 International Medical Devices Plc ("IMD" or "the Company") IMD signs distribution agreement with Inogen Inc - leading supplier of oxygen concentrators International Medical Devices Plc (AIM: INT), the fast-growing medical supplycompany, announces the signing by subsidiary EMS Medical Limited ("EMS Medical")of an exclusive, 4-year rolling distribution agreement effective from February1st 2007 with Inogen, a California based manufacturer of oxygen concentrators,for the Inogen One product. Highlights • EMS Medical signs new exclusive distribution with Inogen • New agreements cover the UK, Norway, Sweden, Denmark, Finland, the Gulf States and Egypt. • Inogen One is among the world's leading personal oxygen supply products • Potential to double EMS Medical sales The exclusive distribution agreement is effective from February 1st as part of afour year rolling agreement, subject to renewal every two years. The Inogen Oneoxygen concentrator will be officially launched by EMS Medical on March 2nd atThe Chronic Obstructive Pulmonary Disease Conference in London. The British Lung Foundation ("BLF") has stated that there are currently 70,000patients in the UK on long term oxygen therapy and BLF estimates that one inseven of the population is affected by a form of lung disease during theirlifetime. Inogen One is unique amongst its peer group as it is lightweight andportable, offering users advantages including greater mobility in every daylife. Inogen One is clinically proven to provide the necessary oxygen for mostambulatory patients during all phases of daily activity and during sleep. Founded in 2001, Inogen (www.inogen.net) develops products that improve thequality of life and increase freedom and mobility for respiratory diseasesufferers, predominantly Chronic Obstructive Pulmonary Disease (COPD) patients.COPD is the fourth leading cause of death in the USA and the only disease withan ever increasing death rate. By 2020 COPD is predicted to become the thirdleading cause of death worldwide. Since inception, investors in Inogen have raised more than US $25 million withkey investors including Versant Ventures, Accuitive Medical Ventures, AvalonVentures, Arboretum Ventures and Novo. IMD Chief Executive Chris Thomas stated, "The signing of the distributionagreement with Inogen is a natural fit for IMD as we already target therespiratory market with products including Breeze and Tubicare through EMSMedical. Inogen One is a revolutionary product for sufferers of respiratorydisease as it is portable and lightweight therefore eliminating theinconveniences experienced by users of other bulkier oxygen units. We lookforward to officially launching Inogen One in London on March 2nd." In May 2006 the Inogen One oxygen concentrator was selected as a recipient ofthe medical design excellence awards in the USA. Inogen One has been designed toperform as a stationery and portable device. Weighing less than 10lbs Inogen Oneallows COPD sufferers to live a more active life, including travel. The FederalAviation Authority (FAA) allows the Inogen One onboard commercial aircrafts.Currently, airlines that allow the use of Inogen One onboard their aircraftsinclude American Airlines, Delta, Continental Airlines, Lufthansa, Air France,SAS and Qantas. EMS Medical will utilise its extensive European and Middle East distributornetworks to sell Inogen One outside the UK. Peter Brenikov, managing director of EMS Medical stated: "This is an outstandingopportunity to generate substantial organic growth into EMS Medical andInternational Medical Devices Plc. Inogen is a superbly managed, technicallyinnovative oxygen solutions company. We are delighted to be their exclusivedistributor in these key markets." Ends For further information, contact: International Medical Devices Corporate Synergy Parkgreen CommunicationsChris Thomas Ian Rice Victoria ThomasCEO+44 203 008 4960 +44 117 933 0020 +44 207 851 7480 About EMS Medical Limited EMS Medical Limited is the distributor of aged care and respiratory devicesunder their brands Kylie, Kanga, Martex, Tubicare and Breeze. Appendix: Inogen One Specifications Weight 9.8lbs (Device 8.3lbs; Battery 1.5 lbs) Size Length: 11.62" Width: 6.00" Height including handle: 12.39" Oxygen Flow Pulse dose delivery system. Five flow settings from 1-5 Power Sensing AC power supply 100-240V, 50-60Hz (auto sensing to allow world wide use) Mobile Power Charger for mobile DC use (will recharge battery) Battery Duration 3 hours, recharge approximately 3 hours with AC or DC power Noise Level Less than 40 decibels Warranty 3 years limited warranty Operation Simple control functions and easy-to-read LCD display Use Stationary, portable and travel This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Intelliam Ai